Founded in 2016, Dyee Capital focuses on healthcare, information technology and green industries. Its management team brings many years of experience in investing, investment banking and industry, a broad network of business contacts, and specialist support for portfolio companies. Its innovative-medicine investments include industry leaders and innovators such as Zelgen (688266.SH), Allist (688578.SH), IONOVA Life Science, Elpiscience, InventisBio, Ark Biosciences and Leads Biolabs.